122 related articles for article (PubMed ID: 34561301)
21. Dauricine attenuates Oct4/sonic hedgehog co-activated stemness and induces reactive oxygen species-mediated mitochondrial apoptosis via AKT/β-catenin signaling in human neuroblastoma and glioblastoma stem-like cells.
Liu C; Yang T; Cheng C; Huo J; Peng X; Zhang Y
Phytother Res; 2024 Jan; 38(1):131-146. PubMed ID: 37821355
[TBL] [Abstract][Full Text] [Related]
22. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects.
Lee JM; Lee YK; Mamrosh JL; Busby SA; Griffin PR; Pathak MC; Ortlund EA; Moore DD
Nature; 2011 May; 474(7352):506-10. PubMed ID: 21614002
[TBL] [Abstract][Full Text] [Related]
23. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
24. BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models.
Hao X; Bahia RK; Cseh O; Bozek DA; Blake S; Rinnenthal J; Weyer-Czernilofsky U; Rudolph D; Artee Luchman H
Neuro Oncol; 2023 May; 25(5):913-926. PubMed ID: 36521007
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
Tivnan A; Tracey L; Buckley PG; Alcock LC; Davidoff AM; Stallings RL
BMC Cancer; 2011 Jan; 11():33. PubMed ID: 21266077
[TBL] [Abstract][Full Text] [Related]
26. TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival.
Chavali PL; Saini RK; Zhai Q; Vizlin-Hodzic D; Venkatabalasubramanian S; Hayashi A; Johansson E; Zeng ZJ; Mohlin S; Påhlman S; Hansford L; Kaplan DR; Funa K
Cell Death Dis; 2014 Oct; 5(10):e1502. PubMed ID: 25356871
[TBL] [Abstract][Full Text] [Related]
27. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis.
Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X
Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736
[TBL] [Abstract][Full Text] [Related]
28. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
[TBL] [Abstract][Full Text] [Related]
29. Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
Jörnsten R; Abenius T; Kling T; Schmidt L; Johansson E; Nordling TE; Nordlander B; Sander C; Gennemark P; Funa K; Nilsson B; Lindahl L; Nelander S
Mol Syst Biol; 2011 Apr; 7():486. PubMed ID: 21525872
[TBL] [Abstract][Full Text] [Related]
30. The Orphan Nuclear Receptor Liver Homolog Receptor-1 (Nr5a2) Regulates Ovarian Granulosa Cell Proliferation.
Meinsohn MC; Morin F; Bertolin K; Duggavathi R; Schoonjans K; Murphy BD
J Endocr Soc; 2018 Jan; 2(1):24-41. PubMed ID: 29379893
[TBL] [Abstract][Full Text] [Related]
31. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
[TBL] [Abstract][Full Text] [Related]
32. The reprogramming factor nuclear receptor subfamily 5, group A, member 2 cannot replace octamer-binding transcription factor 4 function in the self-renewal of embryonic stem cells.
Choi KW; Oh HR; Lee J; Lim B; Han YM; Oh J; Kim J
FEBS J; 2014 Feb; 281(4):1029-45. PubMed ID: 24341592
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
34. Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Cancer Res; 2018 Oct; 78(20):5901-5916. PubMed ID: 30135192
[TBL] [Abstract][Full Text] [Related]
35. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
[TBL] [Abstract][Full Text] [Related]
36. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-433-3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2.
Li J; Gu J; Wang J; You A; Zhang Y; Rao G; Li S; Ge X; Zhang K; Wang D
Brain Behav; 2022 Dec; 12(12):e2632. PubMed ID: 36303447
[TBL] [Abstract][Full Text] [Related]
38. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
[TBL] [Abstract][Full Text] [Related]
39. Extensive neuronal localization and neurotrophic function of fibroblast growth factor 8 in the nervous system.
Tanaka A; Kamiakito T; Hakamata Y; Fujii A; Kuriki K; Fukayama M
Brain Res; 2001 Sep; 912(2):105-15. PubMed ID: 11532426
[TBL] [Abstract][Full Text] [Related]
40. Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Green AL; Ramkissoon SH; McCauley D; Jones K; Perry JA; Hsu JH; Ramkissoon LA; Maire CL; Hubbell-Engler B; Knoff DS; Shacham S; Ligon KL; Kung AL
Neuro Oncol; 2015 May; 17(5):697-707. PubMed ID: 25366336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
